RA Literature Highlights - October 2024

Keywords:

  • Baricitinib, DMARDs, Disease activity, Difficult-to-treat, Efficacy, JAK inhibitors, Meta-analysis, Network Meta-Analysis, Randomized controlled trials, Rheumatoid arthritis, Safety, Systemic review, TNF inhibitors,
  • Literature review thumbnail: RA Literature Highlights - October 2024